Engineering neoantigen vaccines to improve cancer personalized immunotherapy
Engineering neoantigen vaccines to improve cancer personalized immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Engineering neoantigen vaccines to improve cancer personalized immunotherapy have?
Engineering neoantigen vaccines to improve cancer personalized immunotherapy has 49 citations in the OpenAlex counts ScholarIQ stores.
When was Engineering neoantigen vaccines to improve cancer personalized immunotherapy published?
Engineering neoantigen vaccines to improve cancer personalized immunotherapy has 2022 year in the ScholarIQ index.
What is the open-access status of Engineering neoantigen vaccines to improve cancer personalized immunotherapy?
Engineering neoantigen vaccines to improve cancer personalized immunotherapy has gold oa status in the ScholarIQ index.
What is the DOI of Engineering neoantigen vaccines to improve cancer personalized immunotherapy?
The DOI for Engineering neoantigen vaccines to improve cancer personalized immunotherapy is on the source record.
What is the PMID of Engineering neoantigen vaccines to improve cancer personalized immunotherapy?
The PMID for Engineering neoantigen vaccines to improve cancer personalized immunotherapy is on the source record.
What is the OpenAlex record for Engineering neoantigen vaccines to improve cancer personalized immunotherapy?
The OpenAlex for Engineering neoantigen vaccines to improve cancer personalized immunotherapy is on the source record.